Business Context and Reporting Period
Company: NewHold Investment Corp. III (SPAC) and NewCleo Ltd. (Target)
Filing Date: May 27, 2026 (Reporting event date: May 26, 2026)
Event: Entry into a Material Definitive Agreement (Business Combination Agreement) to merge the SPAC with NewCleo Ltd., a private limited company incorporated under the laws of England and Wales. The transaction involves a dual merger structure where the SPAC will become a wholly-owned subsidiary of the re-registered public NewCleo Ltd.
Key Financial Metrics and Transaction Terms
- Base Equity Value: $2,350,000,000 (plus aggregate exercise price of vested options and proceeds from Pre-Closing Equity Financing).
- PIPE Investment: $220,000,000 aggregate purchase price for Company Ordinary Shares at $10.00 per share.
- Minimum Cash Proceeds Condition: The SPAC must have total cash proceeds of at least $200,000,000 (including PIPE and trust cash after redemptions) to close.
- Net Tangible Assets Condition: The SPAC must retain at least $5,000,001 in net tangible assets after shareholder redemptions.
- Warrant Exercise Price: Existing SPAC warrants are exercisable at $11.50 per share; new warrants will be issued to replace them post-merger.
- Non-Redemption Commitment: Certain investors agreed not to redeem up to 923,780 SPAC Class A Ordinary Shares in exchange for the Sponsor forfeiting 92,378 Class B shares and assigning equivalent Company Ordinary Shares.
Material Changes and Transaction Structure
The filing details a significant corporate restructuring and merger:
- Capital Restructuring: NewCleo Ltd. will re-register as a public limited company, redenominate its share capital to U.S. dollars, and consolidate its shares based on a "Recapitalization Factor" derived from the Base Equity Value and a $10.00 reference price.
- Share Conversion: Outstanding SPAC Units will separate into shares and warrants. SPAC Ordinary Shares will convert 1-for-1 into NewCleo Ordinary Shares (subject to redemptions and forfeitures).
- Sponsor Forfeiture: The Sponsor will automatically forfeit a percentage of its securities if the Total Cash Proceeds Amount falls below $400,000,000 (adjusted for transaction expenses).
- Lock-Up Arrangements: Sponsor and certain Company shareholders are subject to an 180-day lock-up period, with performance-based release thresholds at $12.00, $15.00, and $18.00 share prices.
Guidance, Outlook, and Risks
Outlook and Conditions: The transaction is subject to customary closing conditions, including shareholder approval from both the SPAC and NewCleo, regulatory approvals, and the absence of a Material Adverse Effect. The closing is targeted to occur by November 27, 2026 (six months from the agreement date), unless extended or terminated.
Risks and Contingencies:
- Termination Rights: Either party may terminate if the deal is not closed by the Agreement End Date, if shareholder approval is not obtained, or if a Material Adverse Effect occurs.
- Forward-Looking Statements: The filing contains forward-looking statements regarding the ability to consummate the transaction, future operating performance, and the realization of anticipated benefits, which are subject to significant uncertainties.
- Regulatory and Listing: Closing is contingent on the approval of a listing application on the applicable stock exchange and the absence of governmental orders prohibiting the merger.
Investor Verification Checklist
- Verify the final Base Equity Value and the calculation of the Recapitalization Factor in the upcoming Registration Statement (Form F-4).
- Confirm the final amount of shareholder redemptions to ensure the $200 million minimum cash proceeds condition is met.
- Review the PIPE Subscription Agreements for specific investor identities and any additional terms not summarized in the 8-K.
- Monitor the SPAC Shareholder Meeting date and voting results for approval of the Business Combination.
- Check for any updates regarding the re-registration of NewCleo Ltd. as a public limited company in the UK.